Evidence map

ArticleFrontiers in oncology2025

Development of a biomimetic nanoparticle platform for apigenin therapy in triple-negative breast cancer.

Chenyang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40452850